Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol Orally Disintegrating Tablets for Premature Ejaculation
2009-011410-18Phase 3Completed
- Sponsor
- Biovail Laboratories International
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tramadol in premature ejaculation (PE) (3 arms), sponsored by Biovail Laboratories International. Primary endpoints: Intravaginal Ejaculation Latency Time (IELT) and Premature Ejaculation Profile (PEP). Started Jun 2009; status: completed.
02
Drugs
tramadol
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on 2009-011410-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011410-18.